Controlled trial of propranolol in intermittent claudication

Clinical Pharmacology and Therapeutics

Volumn 17, Issue 5, 1975, Pages 612-615

  Reichert, Nira ^a   Shibolet, Shlorno ^a   Adar, Raphael ^a   Gafni, Joseph ^a  

^a HELLER INSTITUTE OF MEDICAL RESEARCH   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROPRANOLOL;

ADULT; AGED; ARTICLE; BUERGER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DETERIORATION; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFECT; DRUG MEGADOSE; ESSENTIAL HYPERTENSION; FEMALE; GENERAL CONDITION IMPROVEMENT; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INTERMITTENT CLAUDICATION; MALE; OUTPATIENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREADMILL TEST; TREATMENT DURATION; DRUG DOSE; DRUG EFFICACY; DRUG THERAPY; MAJOR CLINICAL STUDY; THERAPY; WALKING;

ADULT; AGED; ARTERIOSCLEROSIS OBLITERANS; CLINICAL TRIALS; EXERTION; HUMAN; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGE; PLACEBOS; PROPRANOLOL; THROMBOANGIITIS OBLITERANS;

EID: 0016694605     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1002/cpt1975175612     Document Type: Article

References (13)